Dynamics of Inflammatory Factors in Aqueous Humor During Brolucizumab Treatment for Age-Related Macular Degenerations: A Case Series

Dynamics of Inflammatory Factors in Aqueous Humor During Brolucizumab Treatment for Age-Related Macular Degenerations: A Case Series

Anti-vascular endothelial growth factor (VEGF) treatment with intravitreal brolucizumab (IVBr) was launched as a novel treatment for neovascular age-related macular degeneration (AMD), but the incidence of intraocular inflammation (IOI) as a specific adverse effect of brolucizumab has been reported....

Full description

Saved in:
Bibliographic Details
Main Authors: Masaki Asakage, Hidetaka Noma, Kanako Yasuda, Hiroshi Goto, Masahiko Shimura
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Medicina
Subjects:
age-related macular degeneration
brolucizumab
intraocular inflammation
monocyte chemoattractant protein 1
interleukin-6
interleukin-8
Online Access:https://www.mdpi.com/1648-9144/61/3/372
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/61/3/372

Similar Items